Vtv Therapeutics Inc. (VTVT) — 10-Q Filings
All 10-Q filings from Vtv Therapeutics Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
vTv Therapeutics' Q3 Loss Widens Amid R&D Surge, Cash Reserves Boosted
— Nov 6, 2025 Risk: high
vTv Therapeutics Inc. reported a significant increase in its net loss, reaching $8.7 million for the three months ended September 30, 2025, compared to $4.8 mil -
vTv Therapeutics Narrows Q2 Loss Amid R&D Cuts
— Aug 12, 2025 Risk: high
vTv Therapeutics Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with the prior year periods, indicating its pre-commercia -
vTv Therapeutics Files Q1 2025 10-Q
— May 15, 2025 Risk: low
vTv Therapeutics Inc. filed a 10-Q for the period ending March 31, 2025. The filing details financial information and business operations. The company is incorp -
vTv Therapeutics Files Q3 2024 10-Q
— Nov 12, 2024 Risk: medium
vTv Therapeutics Inc. filed its 10-Q for the period ending September 30, 2024. The company's fiscal year ends on December 31st. The filing includes data from th -
vTv Therapeutics Files Q2 2024 10-Q
— Aug 8, 2024 Risk: medium
vTv Therapeutics Inc. filed a 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the company. Specif -
vTv Therapeutics Inc. Files 10-Q for Period Ending March 31, 2024
— May 9, 2024 Risk: low
vTv Therapeutics Inc. (VTVT) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. vTv Therapeutics Inc. filed its 10-Q report for the quarterly period e
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX